"This is an important day for us at Remilk, and a historic one for Canada as it opens its doors to the new-dairy revolution. We developed a strategic roadmap for regulatory approvals around the world, recognizing that CPG companies seek solutions that benefit consumers throughout North America. We prioritized Canada in our regulatory strategy, following the green light from the FDA," said Aviv Wolff, Remilk's co-founder and CEO. "There's a lot to love in dairy, which is why we set out to create a solution that will enable consumers to enjoy the taste of the dairy they love, without dairy's environmental and health-related drawbacks. The recognition from Health Canada - which follows years of R&D and major investments by Remilk - led to this pivotal moment, enabling a substantial market entry."

Remilk's animal-free BLG milk protein is equivalent to its cow-derived counterpart, but it is produced without a single cow, via precision fermentation. The company manufactures its protein at commercial scale in several locations around the world.

"Health Canada's acceptance of our animal-free protein is additional validation of its safety and purity. Canada's is the fourth separate health administration to conduct thorough examinations of our protein and each, individually, found it to be equivalent to its traditional counterpart," said Dr. Ori Cohavi, Co-Founder and CTO at Remilk. "Regulatory approvals serve to not only open new markets for the sale of our proteins but, also, as reassurance for both industry and consumers that our protein is the same milk protein they have been consuming and enjoying for decades."